InvestorsHub Logo
Followers 13
Posts 1599
Boards Moderated 0
Alias Born 12/14/2016

Re: Brian903 post# 97062

Saturday, 07/27/2019 10:14:41 AM

Saturday, July 27, 2019 10:14:41 AM

Post# of 144814
My latest letter to Investor Relations:

Hello,

https://trentdailytimes.com/2019/07/26/analyzing-amgen-nasdaqamgn-pharmacyte-biotech-nasdaqpmcb.html

It's Oldmusky, again. Could you please explain this article that compares PharmaCyte To Amgen. You are comparing an extremely successful Biotech to one with no revenues. I am not saying PMCB won't be successful, I am saying that comparing PharmaCyte to Amgen in an article such as this is, a red flag, clutching at straws, and quite worrisome.

To a savvy investor this type of a farce of a comparison seems odd and ill timed. It is a very transparent pump with no meat to it. It hurts the companies credibility, not help it. Its a bush league game when we want to hit the big leagues.

I am actually not complaining, please don't take it that way. I am trying to help. Right now your trusted longs are on edge. If this group of dedicated longs leaves you, you will no longer be able to raise money. I would pull this discrediting article and give your loyal following news on cells, testing and file the IND.
SINCERELY TRYING TO HELP, Oldmusky
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News